Welcome to our dedicated page for Avant Brands news (Ticker: AVTBF), a resource for investors and traders seeking the latest updates and insights on Avant Brands stock.
News and updates for Avant Brands Inc. (OTCQX: AVTBF) focus on its activities as a premium cannabis producer with operations across Canada and a growing international presence. Company announcements frequently highlight developments in recreational, medical, and export markets, reflecting Avant’s role in the cannabis sector and its listing on the Toronto Stock Exchange, OTCQX Best Market, and Frankfurt Stock Exchange.
Investors following Avant’s news can expect regular coverage of financial results, including quarterly and annual updates where the company reports on gross and net revenue, export wholesale revenue, cannabis production and sales volumes, and non-GAAP performance measures such as adjusted EBITDA and adjusted net income. These releases often discuss trends in domestic wholesale, recreational revenue, and international sales.
Avant’s news flow also includes strategic and commercial milestones. Examples disclosed by the company include multi-year international supply agreements for GACP-certified dried flower, licensing agreements for its BLK MKT™ brand in overseas markets, and SKU expansions for BLK MKT™ and Tenzo™ in Canadian provinces such as Ontario and British Columbia. The company has also reported on medical platform initiatives under the Avant Medical and GreenTec™ banners.
Corporate and capital markets updates appear in Avant’s news as well, such as annual general meeting results, changes to incentive plans, amendments to warrants and convertible debentures, and the adoption of a shareholder rights plan. Debt-related announcements, including the full repayment of a secured convertible debenture tied to a prior acquisition, have also been featured.
For readers tracking AVTBF, this news stream offers insight into Avant’s operational performance, international expansion, product portfolio evolution, and corporate governance decisions. Regularly reviewing these items can help contextualize the company’s position within the cannabis industry and its strategic priorities over time.
Avant Brands (OTCQX:AVTBF) announced that its board approved a Shareholder Rights Plan effective January 9, 2026, executed with Computershare as rights agent.
The plan is intended to give the Board and shareholders time to consider unsolicited take-over bids, to allow the Board to solicit and negotiate value-enhancing alternatives, and to encourage bidders to provide full and fair value. The company says the plan is similar to modern Canadian rights plans and was not adopted in response to any specific proposal.
The Toronto Stock Exchange has conditionally accepted the plan, subject to customary conditions including ratification by Avant shareholders at the annual meeting in May 2026; if ratified the plan will remain in effect for three years following ratification. A copy of the plan will be posted on SEDAR+ and the company website.
Avant Brands (OTCQX:AVTBF) completed full repayment of its $9.5M amended and restated convertible debenture in November 2025, eliminating its largest monthly debt obligation and releasing secured operating assets.
The repayment is part of ~$4M total debt repaid in Fiscal 2025 and follows eight consecutive quarters of positive Adjusted EBITDA. Year-to-date cash flows from operating activities rose 111% to $3.7M, while Q3 2025 reported revenue increased 13% to $10.8M and gross profit rose 68% to $1.7M. Key real estate assets including Grey Bruce Farms and Tumbleweed Farms are now unencumbered.
Avant Brands (OTCQX:AVTBF) reported Q3 2025 results for the quarter ended August 31, 2025, showing continued operational improvement and positive cash generation.
Key metrics: quarterly gross revenue $10.8M (+13%), net revenue $9.4M (+11%), YTD gross profit $3.1M (+3851%), adjusted EBITDA $0.2M (eighth consecutive positive quarter), and YTD operating cash flows $3.7M (+111%). Domestic wholesale revenue rose sharply (+307%) while export wholesale fell (-16%), producing a combined wholesale total of $6.5M (+17% vs Q3 2024).
Avant Brands (OTCQX:AVTBF) has been named one of Canada's Top Growing Companies by The Globe and Mail for the third consecutive year. The company ranked 138th on the 2025 list with impressive three-year revenue growth of 263%, following its previous rankings of #49 in 2023 and #182 in 2024.
The recognition, part of The Globe and Mail's Report on Business ranking system launched in 2019, celebrates innovative Canadian businesses that meet specific revenue growth criteria. Avant, known for producing innovative and award-winning cannabis products, aims to leverage this momentum for global expansion and strengthen its position in premium markets.
Avant Brands (OTCQX:AVTBF) released its Q2 2025 financial results, marking its sixth consecutive quarter of positive Adjusted EBITDA at $1.2 million. The company reported gross revenue of $9.7 million (+3% YoY) and net revenue of $8.5 million (+3% YoY).
Export wholesale revenue grew 11% to $4.1 million, driven by strong international demand in Germany, Israel, and Australia. Domestic wholesale revenue increased 37% to $1.3 million, while recreational revenue declined 14% to $2.9 million due to strategic SKU optimization. The company's cannabis production reached 3,327 KG (+4%), with sales volume of 2,799 KG (+3%).
However, gross margin adjusted for fair value adjustments decreased to 26% from 37% in Q2 2024, while YTD net cash flows from operations improved by 7% to $2.6 million.
Avant Brands (TSX:AVNT, OTCQX:AVTBF) has announced its annual general and special meeting scheduled for May 30, 2025, at 1:00 p.m. PDT in Kelowna, BC. Key highlights include proposed amendments to previously issued convertible securities:
The company has entered into Repricing Amendments on April 21, 2025, affecting:
- Warrants: Exercise price reduction from $3.00 to $1.75
- Convertible Debentures: Staged conversion price reductions from $3.00 to:
- $1.25 (first 3 months post-approval)
- $1.50 (3-6 months post-approval)
- $1.75 (6 months to maturity)
These amendments remain subject to TSX and shareholder approval. Shareholders of record as of April 14, 2025, will be eligible to vote at the meeting. Meeting materials will be available on the company's website and SEDAR+.
Avant Brands (AVTBF) has reported its Q1 2025 financial results, showing notable growth in several key metrics. Gross Revenue increased 8% to $9.7 million, while Net Revenue rose 7% to $8.6 million compared to Q1 2024.
The company's Export Wholesale Revenue saw significant growth, reaching $4.7 million (+41%), driven by strong demand in Australia, Germany, and Israel. However, Recreational Revenue declined 16% to $2.8 million, and Domestic Wholesale Revenue decreased 28% to $0.9 million following a strategic SKU realignment.
Financial highlights include a Gross Profit increase to $1.6 million (from $0.9 million), marking the fifth consecutive quarter of positive Adjusted EBITDA ($1.7 million) and Adjusted Net Income ($0.5 million). Cannabis production reached 3,326 KG (+3%), with sales volume up 21% to 3,360 KG. The Gross Margin percentage adjusted for fair value adjustments decreased to 34% from 58% due to market price compression and increased cultivation costs.
Avant Brands reported record financial results for fiscal year 2024, with gross revenue reaching $40.0 million (+32% YoY) and net revenue of $35.8 million (+36% YoY). The company achieved significant growth in export wholesale revenue, reaching $19.4 million (+107% YoY), driven by strong international demand from Australia, Germany, and Israel.
Q4 2024 highlights include record gross revenue of $12.1 million (+109% YoY) and net revenue of $11.0 million (+127% YoY). However, the company reported a gross loss of $1.8 million in Q4 2024, compared to a $1.0 million profit in Q4 2023, primarily due to biological asset valuations.
Cannabis production increased 19% to 12,643 kg in FY 2024, while sales volume grew 91% to 13,560 kg. The company maintained positive Adjusted EBITDA and Adjusted Net Income for four consecutive quarters, with Q4 2024 achieving $2.3 million and $2.7 million respectively.